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Arthritis is the most common chronic health condition in Canada, with the most common 
form being osteoarthritis (OA). There is a great clinical need for an objective imaging-
based point-of-care tool to assess OA status, progression, and response to treatment. This 
thesis aims to validate a handheld mechanical three-dimensional (3D) ultrasound (US) 
device against the current clinical standard of magnetic resonance imaging (MRI) for 
quantifying femoral articular cartilage (FAC) volume. Knee images of 25 healthy 
volunteers were acquired using 3D US and 3.0 Tesla MRI scans. Two raters manually 
segmented the trochlear FAC during separate sessions to assess intra- and inter-rater 
reliabilities. The results demonstrated that 3D US has excellent reliability and strong 
concurrent validity with MRI for measuring healthy FAC volume. 3D US is a promising, 
inexpensive, and widely accessible imaging modality that will enable clinicians and 
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Summary for Lay Audience 
Arthritis is the most common disease in Canada, affecting around 21% of the population. 
There are over 100 different types of arthritis, with the most common type being 
osteoarthritis (OA). Medical imaging systems such as x-ray imaging and magnetic 
resonance imaging (MRI) are utilized to diagnose and monitor OA by taking pictures of 
joints such as the knee. Structures within the knee joint are observed to assess disease 
progression and response to treatment. While x-ray imaging is excellent at visualizing 
bone, it cannot visualize soft tissues such as cartilage, ligaments, and fat. It is challenging 
to use x-ray imaging to assess cartilage abnormalities caused by OA. MRI is excellent at 
visualizing soft tissues, but MRI systems are expensive to operate and have long waitlists 
and imaging times. Furthermore, neither x-ray imaging nor MRI can be used to acquire 
images at the patient’s bedside. There is a tremendous clinical need for an imaging 
system that can assess knee cartilage at the patient’s bedside without the limitations of x-
ray and MRI. This work aimed to use 3D ultrasound (US) imaging to meet this clinical 
need and compare it against MRI for measuring knee cartilage volume. 
Knee images of 25 healthy volunteers were acquired using MRI and 3D US. Two raters 
traced the cartilage from MRI and 3D US images to measure the cartilage volume. The 
cartilage was traced multiple times to assess the reliability of each rater. The cartilage 
volumes were compared between MRI and 3D US to evaluate the performance of 3D US 
against the current clinical standard of MRI. The results demonstrated that clinicians and 
researchers could use 3D US to measure knee cartilage volume at the patient’s bedside 
with excellent reliability and strong agreement with MRI. 3D US is a promising, 
inexpensive, and widely accessible imaging modality that will enable clinicians and 





This thesis contains one manuscript that has been published as an original research 
article. As the first author of this manuscript, I contributed significantly to all aspects of 
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Chapter 1  
1 Introduction 
Medical imaging has advanced drastically since the discovery of x-rays in 1895 by 
Wilhelm Rӧntgen. Currently, radiologists are capable of observing the human body with 
magnificent detail through the use of x-ray radiography, computed tomography (CT), 
magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound 
(US), and various other modalities.1 Medical imaging has had significant positive impacts 
on diagnosing, monitoring, and treating various diseases. As technologies continue to 
improve, new imaging modalities are being developed to overcome challenges in 
visualizing the human body and treating various diseases. However, with the growth of 
medical imaging, concerns over radiation risks, high manufacturing and operating costs, 
and accessibility to many patients have intensified.2 It is vital to keep these concerns in 
mind when developing new modalities to increase their accessibility and effectiveness for 
disease diagnosis and monitoring. 
Diagnosing and monitoring musculoskeletal diseases can be accomplished with medical 
imaging using x-ray radiography, MRI, and US. However, these methods are associated 
with limitations in sensitivity and accuracy when assessing musculoskeletal diseases such 
as arthritis.3 Therefore, there is an unmet clinical need for a new imaging tool to directly 
visualize musculoskeletal disease pathology for assisting in diagnosis and monitoring 
response to therapy. Three-dimensional (3D) US imaging is a relatively new modality 
that can meet this clinical need and overcome the limitations of x-ray radiography, MRI, 
and conventional US. This thesis will explore the application of handheld 3D US imaging 
as a lower-cost imaging modality to provide clinicians and researchers with the ability to 
monitor arthritis progression and response to treatment. This thesis will specifically 
investigate the application of 3D US imaging to monitor knee arthritis progression, but 
3D US techniques have been applied to other areas such as neonatal, gynecological, and 
vascular applications, among others.4,5,6 3D US imaging has the potential to alter the 
workflow of orthopedic, sports medicine, primary care, and arthritis clinics by enabling 





arthritis and current methods of diagnosis, treatment, and monitoring. It also outlines the 
underlying principles of 3D US imaging and medical image processing techniques and 
describes the unmet needs, hypothesis, and specific objectives of this thesis. 
1.1 Knee osteoarthritis 
Arthritis is the most common chronic health condition in Canada, affecting 
approximately 21% of the population.7 There are over 100 different forms of arthritis, 
including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other 
inflammatory forms.8 The most common form of arthritis is osteoarthritis (OA) which 
was previously thought to be caused by the “wear and tear” of joint tissues such as 
cartilage and the underlying bone. However, OA is a whole-joint disease and is described 
as an abnormal remodelling of joint tissues caused by a host of inflammatory agents. OA 
can affect any joint in the body, with the most common sites being the knee and hip.9 
Patients with OA suffer from debilitating pain, disability, and a decreased quality of 
life.10 Furthermore, OA has high comorbidity with other chronic health conditions such 
as cardiovascular diseases, diabetes mellitus, and depression.11,12,13,14 The presence of 
comorbidities causes higher mortality, increased hospitalization, poor physical and 
mental health, and worse disease outcomes.15 
Knee OA (KOA) is of particular importance to study because of its high prevalence rate 
compared to other types of OA and its appearance earlier in life, specifically in young 
obese women.16 The prevalence of KOA is higher for women than men and is higher in 
older age groups.17 Females over 55 years tend to experience more severe OA in the knee 
joint but not in other sites.18 Furthermore, the prevalence of KOA is increasing with 
rising obesity rates and population ageing.19 The impact KOA has on an individual’s 
quality of life, and its high prevalence, stresses the need for further research. 
1.1.1 Risk factors 
A risk factor is a variable associated with an increase in the risk of a particular disease. 
Variables that affect the risk of KOA include age, biological sex, congenital joint 
abnormalities, history of injury, body mass index (BMI), occupational factors, physical 





life, with the highest incidence between 55 and 64 years of age.20 Many studies have 
demonstrated consistent evidence that females are at higher risk for KOA than males, 
according to biological sex.21 Large areas of cartilage loss can lead to joint malalignment, 
which is the most significant risk factor for knee structural degradation due to unequal 
focal loading.22 Joint malalignment can also be congenital, increasing the risk of KOA 
incidence. Anterior cruciate ligament and meniscal injuries are substantial risk factors for 
KOA at ten or more years following injury.23 Studies assessing BMI demonstrated that 
being overweight (BMI between 25 and 29.9) or obese (BMI of 30 and over) increases 
the risk for KOA.24 OA environmental risk factors such as obesity, joint injury, and joint 
overload are primarily mechanical in nature. Studies have shown that muscle weakness, 
joint instability, and malalignment may be possible causes of KOA rather than results of 
KOA-induced joint damage.25,26 There is some evidence that various occupation-related 
movements such as kneeling, squatting, climbing steps, excessive standing, and lifting 
increase KOA risk.24 Physical activity is a recommended treatment option for KOA, but 
there is mixed evidence, with habitual and high-intensity physical exercise leading to an 
increased KOA risk.21,24 In healthy and KOA joints, metabolism plays an essential role in 
remodelling various joint tissues.27 Cartilage softening and catabolism have been 
observed in patients with diabetes, although there is little evidence to conclude that 
impaired glucose metabolism increases KOA risk independent of obesity and age.28,29 
Risk factors play an essential role in detecting and preventing KOA. 
1.1.2 Knee anatomy 
The knee is the largest synovial joint in humans and contains the distal femur, proximal 
tibia, patella, meniscus, hyaline cartilage, ligaments, and a synovial membrane.30 KOA 
leads to articular cartilage loss of the femur, tibia, and patella. KOA also results in 
subchondral bone remodelling, synovial inflammation (synovitis), and periarticular 
muscle weakening (Fig. 1).31 Localized cartilage loss increases the stress across the knee 
joint, which leads to further cartilage degradation and loss. The limited intrinsic healing 







Figure 1.1 Anatomical diagrams depicting the difference between a normal knee and an 
osteoarthritic knee involving articular and periarticular tissues. Reproduced with 
permission from Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021;384:51-59. 
Doi:10.1056/NEJMcp1903768, Copyright Massachusetts Medical Society. 
Articular cartilage is classified as hyaline cartilage and has an average thickness ranging 
between 2 to 4 mm. It does not contain blood vessels, lymphatics, or nerves and is 
composed of a dense extracellular matrix (ECM) and a sparse distribution of specialized 
cells called chondrocytes.33 Chondrocytes are responsible for synthesizing articular 
cartilage during development, maintaining normal adult cartilage, and the degeneration of 
cartilage during KOA.34 Proteoglycans, a type of protein, are embedded within the 
collagen matrix of the cartilage and draw water into the cartilage.10 The high water 
content of the cartilage provides resistance to compressive forces within the joint. In 
addition to collagen fibre structure and ECM, chondrocytes contribute to the organization 
of four zones within articular cartilage: the superficial zone, the middle zone, the deep 





articular cartilage to the bone by anchoring the deep zone’s collagen fibrils to the 
subchondral bone.33 A sharp boundary referred to as the tidemark separates the non-
calcified and calcified cartilage zones.35 In OA, the tidemark commonly becomes 
replicated, which is taken as an indicator of the underlying osteoarthritic process with the 
calcification front advancing into the non-calcified cartilage of the deep zone.36,37 
1.1.3 Clinical presentation and symptoms 
OA can only be clinically diagnosed if patients present with symptoms, and preventing or 
alleviating these symptoms is the goal of the intervention.10 The most common OA 
symptom is joint pain, which tends to worsen with activity, especially following a rest 
period.38 KOA patients frequently complain of joint instability leading to buckling, 
especially when descending stairs or steps.39 Physician examinations of KOA patients are 
coupled with medical imaging to determine disease presence and severity.10 
Traditionally, weight-bearing radiography has been used to diagnose KOA through 
measuring tibiofemoral (TF) joint space narrowing (JSN), which serves as an indirect 
measure of femoral articular cartilage (FAC) loss. Medical imaging is rarely required to 
confirm the diagnosis of KOA; however, imaging is helpful to evaluate the severity of 
joint damage and to monitor disease progression longitudinally.40 Semi-quantitative 
scoring systems, such as the Kellgren-Lawrence (KL) grading scale and the Osteoarthritis 
Research Society International (OARSI) atlas grading system, define the presence of 
KOA using TF JSN, where decreases in FAC quality and quantity are interpreted as 
increased KOA severity.41,42 The KL grading scale defines OA severity in five grades (0-
4, normal to severe) using a combination of osteophyte and JSN severity. The OARSI 
atlas uses separate scoring for osteophytes and JSN (grading 0-3). Using the KL system, a 
grade ≥ 2 is the typical threshold for OA, while the OARSI atlas threshold consists of 
three separate criteria: either JSN grade ≥ 2, osteophyte grade ≥ 2, or grade 1 JSN in 
combination with grade 1 osteophyte.43,44 
1.1.4 Progression and treatment 
In OA, the articular cartilage matrix undergoes proteolytic degradation, which is 





the chondrocytes.45 This results in early morphological changes in the cartilage and later 
losses in cartilage volume. Osteophyte development and significant vascularity changes 
within bone might play an essential role in the pathogenesis of OA, but these events are 
less understood. Furthermore, signalling molecules released from the cartilage, 
synovium, and bone all have an impact on chondrocyte function. Although OA was 
previously thought of as non-inflammatory arthritis, improved detection methods 
demonstrate that inflammatory pathways are upregulated in OA.46  
While there is no cure for OA, several treatment avenues and methods focus on 
alleviating symptoms with varying efficacies. The European League Against Rheumatism 
and OARSI have previously published evidence-based OA treatment 
guidelines.47,48,49,50,51 The American College of Rheumatology has published the most 
recent guidelines for managing hand, hip, and knee OA.52 One treatment option for KOA 
is regular physical exercise. Regular physical activity in KOA patients effectively reduces 
pain and improves function.53 Improving knee joint stability is vital to prevent worsening 
KOA, particularly by increasing strength in the quadriceps and peripheral muscles around 
the joint.54 Strength, flexibility, aquatic and aerobic exercises effectively relieve pain and 
improve function in patients with lower limb OA.55 For obese patients, weight loss can 
reduce the risk of developing symptomatic lower limb OA and improves symptoms once 
disease evidence is found.56,57 Studies have also demonstrated that weight loss leads to 
structural improvements of cartilage and positive changes in bone and cartilage 
biomarkers, especially in KOA.58,59 However, weight reduction is not easy, and patients 
with lower limb OA have pain and physical limitations that limit their ability to 
participate in physical activity compared to the general population.60,61 
Another KOA treatment option is the use of pharmaceutical therapies. Commonly 
prescribed medications include paracetamol (also referred to as acetaminophen), 
corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs).62 Due to its cost and 
safety, paracetamol used to be regarded as the first-line treatment for mild to moderate 
OA pain.63 However, systematic reviews and meta-analyses of paracetamol use in KOA 
patients suggest low efficacy for pain management.64,65 NSAIDs are an alternative to 





upper gastrointestinal risks and are not recommended for patients with coexisting 
cardiovascular conditions.52,63,66,67 Intra-articular treatment options such as glucocorticoid 
and hyaluronic acid injections may be recommended when other more conservative 
approaches to pain relief have failed. However, intra-articular injections elicit a strong 
placebo effect, and new intra-articular treatments may not be appropriate for every 
patient.68,69 Ultimately, there is no pharmacological agent that regulatory agencies have 
approved as a disease-modifying OA drug.70 
In addition to physical activity and pharmacological treatment options, surgical 
intervention may alleviate KOA symptoms. Arthroscopy is a minimally invasive surgical 
technique where two small incisions are made at the front of the knee to insert surgical 
instruments.71 Arthroscopic lavage (irrigation of the joint using a sterile solution) and 
debridement (resecting damaged tissue within the knee joint) is focused on removing 
loose bodies or other defects in the knee.72 However, the use of arthroscopic lavage and 
debridement to treat KOA is controversial as studies have shown no benefit compared to 
placebo groups that received only skin incisions.73,74 Other KOA surgical interventions 
include high tibial osteotomy, unicompartmental knee replacement, and total knee 
arthroplasty (TKA), also referred to as total knee replacement, for end-stage KOA.75 
Approximately 80% of patients that undergo TKA procedures are satisfied with their 
procedure and experienced improvements in function and pain management, making 
TKA an effective treatment option for end-stage KOA.76 
Another treatment option for KOA is the use of self-efficacy and self-management 
programs, which can be delivered remotely and include education, setting goals, 
behavioural interventions, and self-monitoring.77 These programs have shown improved 
self-efficacy in patients with KOA in small to moderate effect sizes.78 Furthermore, 
mental and social well-being improvements are also effective treatments for some 
patients due to the many components of pain, including sleeping problems, loneliness, 





1.2 Knee osteoarthritis imaging 
1.2.1 X-ray radiography 
X-ray radiography is the current gold standard for assessing KOA in clinical and 
epidemiological settings. In 1957, Kellgren and Lawrence first described a grading 
system known as the KL grading scale, which was adopted as the standard method for 
assessing radiographic OA by the World Health Organization in 1961.81 In 1995, an atlas 
from OARSI was published and updated in 2007 with better quality images and access to 
electronic images.42,82 Radiography is widely available and is associated with lower costs 
than MRI. Radiography acquisition times are short, and there is little discomfort to 
patients undergoing imaging. The progression and severity of KOA can be monitored 
using radiography by assessing cartilage degradation through measurements of JSN and 
through observing the presence of osteophytes (Fig. 2). 
There are several limitations associated with radiography and radiographic grading scales 
for monitoring the progression of KOA. Primarily, radiography lacks soft tissue contrast, 
and therefore it cannot be used to visualize the articular cartilage and various other tissues 
within the knee. Radiographic measures of JSN operate under the assumption that 
decreases in joint space over time represent decreased articular cartilage volume. This 
assumption is not entirely valid since the radiographic joint space comprises structures 
other than the articular cartilage, such as the meniscus.83,84 Radiographic grading also has 
poor sensitivity to detect articular cartilage changes in the early stages of KOA.85 With 
radiographic JSN, variations in knee positioning, alignment to the radiographic source, 
and joint angulation can decrease reliability and reproducibility.86 Furthermore, 
sensitivity to change is limited when using ordinal scales with a small dynamic range 






Figure 1.2 Radiographs of a normal (A) and an osteoarthritic (B) knee. The distance 
between the femur and tibia in the medial portion of the osteoarthritic knee is smaller 
than the healthy knee due to articular cartilage degradation. 
1.2.2 Magnetic resonance imaging 
The limitations of radiographic measures of articular cartilage degradation motivated 
MRI studies focused on imaging and monitoring KOA. While the risks associated with 
radiation exposure in radiography are low, MRI does not expose patients to radiation as 
images are created using magnetic fields. MRI has excellent soft-tissue contrast enabling 
direct assessments of the articular cartilage. The posterior condylar cartilage, trochlear 
cartilage, patellar cartilage, synovium, menisci, and other soft tissues affected by KOA 
are more straightforward to visualize using MRI than radiography (Fig. 3). MRI’s high 
spatial resolution, excellent soft-tissue contrast, and ability to directly visualize vital 
musculoskeletal tissues make it the current clinical standard for KOA imaging. The use 
of MRI in clinical KOA studies involves using semi-quantitative scoring methods to 





of the surrounding tissues to establish symptom risk factors and disease progression.86 
The 3D nature of MRI enables assessments of multiple quantitative articular cartilage 
measures, including cartilage volume, thickness, surface area, and percentage of bone not 
covered by cartilage. MRI-based quantitative measurements can also be used to assess 
the efficacy of pharmacologic therapies in KOA and cartilage biochemistry to monitor 
early-stage KOA. The MRI Osteoarthritis Knee Score (MOAKS), Boston-Leeds 
Osteoarthritis Knee Score (BLOKS), Knee Osteoarthritis Scoring System (KOSS), and 




















Measurements of articular cartilage thickness using MRI have been investigated as a 
quantitative alternative to radiographic JSN measures to determine KOA severity and 
progression.91 However, articular cartilage thickness measurements are associated with 
limitations for KOA assessments. The thickness of articular cartilage in the knee joint 
varies diurnally, while the cartilage volume does not, leading to variability in thickness 
measurements.92 Additionally, longitudinal assessments of cartilage thickness changes 
are limited by reselecting the identical section of cartilage for measurements in future 
sessions.93 An alternative to cartilage thickness measurements for assessing degradation 
is cartilage volume. Measurements of articular cartilage volume enable the entire 
cartilage structure to be assessed instead of a single anatomical slice with thickness 
measurements. 
Although MRI has excellent soft-tissue contrast for monitoring the progression and 
severity of KOA, it is associated with several limitations. MRI is not feasible for point-
of-care (POC) disease monitoring due to the limited mobility and physical size of MRI 
systems. Patients diagnosed with KOA may have substantial mobility limitations and 
severe pain when moving from one location to another. Another limitation of MRI is its 
high manufacturing and operating costs. Installing an MRI scanner requires constructing 
a specialized MRI scanning facility which increases costs and may not be possible in all 
locations where MRI would be needed. The limited number of MRI scanners available 
for clinical use in Canada results in patients being placed on long waitlists before 
receiving the imaging necessary for their care. Additionally, the time it takes to acquire 
an MRI scan can be long, requiring patients to remain motionless throughout the entire 
acquisition process. The long scan time is not ideal for patients that experience pain when 
remaining motionless in the positions required for MRI acquisitions. An ideal imaging 
modality for monitoring the progression and response to treatment of KOA would be 
capable of bedside image acquisition, be widely available, have low operating and 
manufacturing costs, and have relatively short acquisition times. 
1.2.3 Conventional ultrasound 
Conventional two-dimensional (2D) US imaging is a high-resolution, widely accessible, 





received by a transducer. Conventional 2D US is capable of real-time imaging, meaning 
that 2D US images are continually acquired as the transducer is manipulated on the 
patient’s skin. The real-time imaging capability enables the operator to rapidly interrogate 
an entire region-of-interest (ROI). Additionally, real-time imaging enables images of the 
patient to be acquired during flexion or extension of their joints to assess how joint 
tissues respond to the motion. The handheld nature of 2D US enables the operator to 
manipulate the transducer in any orientation to acquire images that would be difficult or 
impossible to acquire with radiography. The portability of US machines also enables 
images to be acquired directly at the patient’s bedside, increasing accessibility to patients 
without increasing patient discomfort. 2D US imaging has been increasingly used to 
assess rheumatological and musculoskeletal diseases. Previous studies have demonstrated 
that US can be used to detect early inflammatory soft tissue and erosive bone lesions with 
correlations to MRI, one of the current clinical standards for monitoring arthritis.94,95,96,97 
The Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) US group 
has developed a semi-quantitative grading scale to implement 2D US into KOA research; 
however, this scale has not been formally validated.98 Due to its high water content, FAC 
appears hypoechoic or darker and is easy to visualize using 2D US to monitor the 
progression of KOA (Fig. 4a). The suprapatellar synovial membrane is also visible using 
2D US, enabling assessments of synovitis in KOA patients (Fig. 4b). 
There are several limitations associated with conventional 2D US imaging. Since 2D US 
is a 2D imaging modality, it is difficult to interpret the 3D anatomy. Operators must 
cognitively integrate multiple 2D images to reconstruct the necessary 3D anatomy, which 
is inefficient and can lead to variability. 2D US techniques can estimate tissue volumes 
from measurements of height, width, and length in two orthogonal views by assuming 
idealized geometries. However, 2D US tissue volume measurements are associated with 
low accuracy, high variability, and high operator dependency during image acquisition. 
Additionally, human tissues are not always easily represented by idealized geometries, 
which is especially the case for the FAC and suprapatellar synovium in the knee, leading 
to incorrect volume estimations. With 2D US, it is impossible to acquire viewing planes 
perpendicular to the length of the transducer without rotating the transducer and changing 





monitoring, which may require an arbitrary selection of viewing planes for assessments 















Figure 1.4 2D US images of the trochlear FAC (A) and suprapatellar synovial bursa (B) 
of a healthy knee. Images were acquired with an Aplio i800 US machine (Canon Medical 
Systems Corporation, Ōtawara, Tochigi, Japan) equipped with a 14L5 linear transducer 
(frequency range 3.8 MHz - 10.0 MHz). 
Another limitation of conventional 2D US imaging is that the field-of-view (FOV) is 













image acquired using a linear transducer is determined by the length of the transducer 
itself. The axial dimension of a conventional 2D US image is the depth at which the 
image is acquired. Higher frequency 2D US transducers result in increased spatial 
resolution but decreased penetration depth. In general, conventional 2D US cannot image 
deep tissues at high spatial resolutions. It is difficult to interrogate entire tissues of 
interest with a single 2D US image due to the limited FOV. Multiple images are often 
required, leading to difficulties with interpretation without the surrounding contextual 
anatomy. Furthermore, conventional US imaging is not well-suited to image bony or air-
filled anatomy, making it challenging to acquire 2D US images of the knee joint due to 
the presence of the patella, femur, and tibia. 
1.3 3D ultrasound imaging 
The limitations of conventional 2D US imaging can be overcome using 3D US imaging. 
3D US operates on the same physical principles as conventional 2D US imaging, where 
images are created by transmitting and receiving acoustic waves. 3D US imaging 
provides the operator with an interactive 3D representation of the anatomy eliminating 
the need for mentally reconstructing several 2D US images simultaneously. Three main 
factors must be optimized during the acquisition of 3D US images: 
1. The scanning must be sufficiently rapid to avoid image artifacts due to 
involuntary operator and patient motion. 
2. The location and orientation of the 2D images must be accurately known to avoid 
geometric distortions in the reconstruction of the 3D image. 
3. The scanning device must be simple and easy to operate to avoid complicated 
scanning procedures.99 
Several methods for acquiring 3D US images have been developed that satisfy these 
optimization factors. One approach uses a 2D array of transducer elements, also referred 
to as a matrix array, which enables acquisition in two simultaneous imaging planes. 
However, many elements and wiring requirements lead to high manufacturing costs.100 
Another method of acquiring 3D US images is for the operator to manipulate a 2D 





position and orientation during acquisition.101,102 The position and orientation of the 
transducer can be tracked in real-time using an external optical tracking system that uses 
infrared cameras to track passive marker spheres that can be mounted to the transducer. A 
minimum of three spheres in a non-linear orientation is needed to track all degrees of 
freedom during transducer manipulation. An additional approach is to translate a 
conventional 2D US transducer along a path using a motorized drive mechanism with a 
known trajectory.103 With this approach, 3D US images are formed by continually 
acquiring consecutive 2D US images as the transducer is translated along the subject to 
sweep out a 3D geometry. Consecutive 2D US images are then reconstructed to form a 
3D volume using automated software.99 This thesis focuses on applying mechanical 3D 
US imaging to monitoring KOA. 
With mechanical 3D US image acquisition, there are different trajectories that the 
transducer can follow to produce unique 3D image geometries. Tilt scanning enables the 
transducer to be tilted around a contact point with the patient to sweep out a fan 
geometry. With tilt scanning, 2D US images are acquired at regular angular intervals with 
images radial to the rotation axis. However, the fan geometry of tilt scanning is 
associated with limitations. The varying distances between consecutive 2D US images as 
depth increases result in an anisotropic spatial resolution for the resulting 3D image. 
Additionally, US beam spreading in the elevational direction and within the 2D US 
acquisition plane leads to degradation of the spatial resolution with increasing depth.104 
Alternatively, a linear scanning device translates the transducer linearly along the 
patient’s skin. With linear scanning, 2D US images are acquired at regular spatial 
intervals to sweep out a rectangular geometry. The rectangular geometry of linear 
scanning provides a broader FOV at shallow depths but a smaller FOV at increased 
depths than tilt scanning. Therefore, linear scanning would be better suited for monitoring 
KOA progression due to the superficial knee anatomy. 
3D US images are comprised of multiple imaging planes. The imaging plane that is 
parallel to the direction of conventional 2D US is referred to as the acquisition plane, 
while the perpendicular plane is referred to as the reconstruction plane (Fig. 5). The 





acquire the images. In contrast, the reconstruction plane has a spatial resolution equal to 
the elevational resolution of the transducer. The different spatial resolutions of these two 
imaging planes result in an anisotropic spatial resolution for the overall 3D US image. 
The translation speed of the 2D US transducer on the 3D US scanner can be varied to 
match the sampling rate to the frame rate of the US machine. The translation distance and 
speed of the US transducer also affect the 3D US acquisition time. Typically, 3D US 













Figure 1.5 3D US image of the trochlear FAC from a healthy knee with labelled 
acquisition and reconstruction planes. 
With mechanical 3D US acquisition, the drive mechanism’s housing can be designed to 





flexibility in design, the transducer mounting attachment can be designed to conform to 
any transducer, making 3D US compatible with any US machine. Additionally, since 3D 
US acquisition forms images using consecutive 2D US images, it can be implemented in 
any application where 2D US is used. 3D US imaging also reduces variability and user 
dependency when measuring tissue volumes and provides the ability to select any 
arbitrary imaging plane for disease diagnosis and monitoring. 
1.4 Medical image processing and analysis 
1.4.1 Segmentation 
Image segmentation, also referred to as labelling or contouring, is the process of 
identifying image pixels or defining boundaries for all pixels within a given group or 
region that share a common property or belong to the same tissue type or organ.105 
Segmenting anatomical structures from medical images provides a unique visualization 
of the tissues of interest without the surrounding anatomical information. The gold-
standard method for image segmentation is manual segmentation, which is completed 
manually by tracing regions within an image that belong to the tissue of interest. 
Becoming proficient in manual image segmentation requires training and practice and the 
necessary anatomical and medical imaging background knowledge for a given 
application.106 Segmentations of FAC are necessary to acquire thickness, surface area, 
and volume measurements. The quality of the segmentation also directly impacts the 
accuracy of the measurements.107,108 However, manually segmenting images is subjective 
as the individuals performing the task make their own decisions based on prior 
knowledge and experience, leading to inconsistencies.109,110 
1.4.2 Registration 
In medical imaging, registration is a processing technique that is used to align two or 
more images or segmentations of the same scene taken at different times, viewpoints, or 
with different modalities.111 Image or segmentation registration is used to compare or 
combine valuable information in multiple images or segmentations. Applications of 
registration in the medical imaging field include the fusion of anatomical and functional 





interest.112 Registration involves designating one image or segmentation as the reference 
and applying a geometric transformation to the other image or segmentation to align it 
with the reference.113 Comparing segmentation-based measurements of KOA 
progression, such as FAC volume, provides the ability to assess the performance of new 
methods for acquiring these measurements. 
1.5 Challenges in imaging-based knee arthritis monitoring 
1.5.1 Previous work and unmet need 
Developing new imaging modalities, or repurposing existing technologies for novel 
applications, requires rigorous testing and validation before implementation into standard 
clinical care. When working with new applications, it is crucial to evaluate the workflow 
for feasibility in a clinical setting and validate the system’s measurement capabilities and 
accuracy. We have previously validated the measurement errors of our tilt and linear 3D 
US scanning devices with tungsten filament phantoms and volumetric agar phantoms. 
The linear scanner demonstrated the ability to acquire Euclidean distance and volumetric 
measurements with errors < 2% compared to the known phantom dimensions.114 
However, measurements made from US images can be subject to intra- and inter-rater 
variabilities, and idealized phantom images may not represent complex human anatomy. 
Therefore, a study with human volunteers that possess healthy knees is needed to test the 
intra- and inter-rater reliabilities of using our 3D US device to measure the volume of 
FAC and develop an efficient clinical workflow. 
1.5.2 Hypothesis 
The central hypothesis of this thesis is that 3D US imaging can be used to quantify the 
volume of FAC with similar reliability and accuracy to the current clinical standard of 
MRI. 
1.5.3 Objectives 





1. Assess the intra- and inter-rater reliabilities of manual FAC segmentations of 
healthy knees from MRI and 3D US. 
2. Assess the validity of segmentation-based FAC volume measurements using 3D 
US compared to the current clinical standard of MRI in healthy knees. 
In this context, validity refers to the degree of similarity between manual segmentation-
based FAC volume measurements acquired using 3D US imaging in comparison to FAC 
volume measurements acquired using MRI in healthy volunteers. 
1.6 Thesis outline 
This thesis will address the specific objectives in one manuscript (Chapter 2). 
Chapter 2: Reliability and concurrent validity of three-dimensional ultrasound for 
quantifying knee cartilage volume 
Chapter 2 describes our work on developing and validating a handheld mechanical 3D 
US acquisition device that will be used to monitor the progression of KOA. The ability to 
monitor the progression of KOA at the patient’s bedside will improve clinical workflow 
by enabling clinicians and researchers to obtain more information without added 
complexity or additional stress and discomfort to patients. This device will be beneficial 
in longitudinal and interventional studies to detect FAC volume changes over time. 
Our handheld mechanical 3D US device demonstrated excellent intra- and inter-rater 
reliabilities and strong concurrent validity with MRI when acquiring FAC volume 
measurements from healthy knees. 3D US imaging can decrease the overall costs of KOA 
monitoring and significantly improve the feasibility of FAC volume measurements 
during KOA clinical trials and patient care. 
Chapter 3: Conclusions and future work 
This chapter provides an overall conclusion of the previous chapter and will discuss 
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Chapter 2  
2 Reliability and concurrent validity of three-dimensional 
ultrasound for quantifying knee cartilage volume 
Handheld 3D US imaging has the potential to improve clinical workflow and decrease 
the overall costs of KOA imaging and monitoring at the patient’s bedside. The purpose of 
Chapter 2 is to present the validation of a handheld mechanical 3D US acquisition device 
for measuring the volume of FAC compared to MRI. 
The contents of this chapter have previously been published in Osteoarthritis and 
Cartilage Open: Papernick S, Dima R, Gillies DJ, Appleton CT, Fenster A. 
Osteoarthritis and Cartilage Open. 2020;2(4). The author retains the right to reuse this 
article in this thesis – Appendix B. 
2.1 Introduction 
KOA is a whole-joint disease with a prevalence of 7-17% among adults 45+ years old 
and is increasing with rising obesity rates and population ageing.1,2 KOA affects all knee 
joint tissues, leading to cartilage degradation, subchondral bone remodelling, and muscle 
atrophy.3 Cartilage degradation, a hallmark of KOA, has motivated efforts to characterize 
disease severity through measures of FAC loss, where decreases in FAC quality and 
quantity are interpreted as increased KOA severity. Semi-quantitative scoring systems, 
such as the KL grading scale, define the presence of KOA using TF JSN as a surrogate 
for FAC loss. Most imaging-based KOA scales target TF cartilage because of easy 
visualization with weight-bearing radiography. Although radiographic JSN may represent 
FAC loss, radiographic grading has poor sensitivity to detect FAC changes in early-stage 
KOA.4 Furthermore, radiographic JSN suffers from limited reproducibility for visualizing 
3D features due to variations in knee joint angulation.5 Additionally, JSN is a composite 
of meniscal positioning and degeneration, which are not necessarily associated with KOA 
severity.6,7 
Limitations of radiographic JSN have motivated MRI investigations of FAC as a 





are all MRI-based semi-quantitative scales that have shown excellent reliabilities in OA 
populations.8,9,10,11 Furthermore, compositional MRI techniques produce quantitative 
measurements of cartilage biochemistry and have primarily been developed to investigate 
early-stage KOA. Due to the ability of MRI to assess the status of whole joint cartilage 
with reasonable spatial resolution, it has been largely accepted as the gold standard for 
KOA FAC assessments. While MRI has accelerated the scientific and medical 
communities’ understanding of KOA, it has limitations. MRI is not feasible for POC 
disease classification due to high manufacturing and operating costs, long acquisition 
times, and inaccessibility to all patients at all times.12 However, while other modalities 
may be less expensive and more accessible than MRI, finding individuals that possess the 
expertise needed to interpret images in under-served areas of the world is challenging. 
Conventional 2D US is widely accessible, relatively inexpensive, and overcomes the 
limitations associated with MRI. 2D US is a high-resolution imaging modality that has 
been increasingly used for POC assessments of rheumatological diseases.13,14,15,16 2D US 
has been implemented in KOA research via OMERACT US working group’s semi-
quantitative grading scale.17 However, this scale has not been formally validated, and 
conventional 2D US is associated with limitations. Clinicians must cognitively integrate 
multiple 2D images to mentally reconstruct 3D anatomy, which is inefficient and leads to 
operator variability.18 Additionally, 2D US tissue volume calculations require 
measurements of height, width, and length in two orthogonal views and are associated 
with low accuracy, high variability, and large operator dependency. Furthermore, 
sensitivity to change is limited when using ordinal scales with a small dynamic range 
such as 0-3 in the OMERACT scale. Alternatively, 3D US techniques involve translating 
a 2D US transducer while continually acquiring images that are reconstructed into a 3D 
image. 3D US imaging overcomes the limitations of 2D US and may fill the clinical need 
for an objective imaging-based POC tool for assessing KOA status, progression, and 
response to treatment. 
3D US techniques have been applied to neonatal, gynecological, and vascular 
applications, among others.19,20,21 We have developed a handheld mechanical 3D US 





cross-sectional study were to investigate the intra- and inter-rater reliabilities of our 3D 
US scanner for measuring tFAC volumes in healthy volunteers and assess its concurrent 
validity compared to the current clinical standard of MRI. We hypothesized that tFAC 
volumes measured from 3D US would demonstrate excellent reliability (ICC > 0.90) and 
be strongly correlated (ρ > 0.80) to MRI measurements in the same ROI. 
2.2 Methods 
Twenty-five volunteers over the age of 18 without a recent history of chronic knee joint 
pathology (healthy knees) in the year prior to the study were recruited for MR and 3D US 
knee imaging. The imaging protocol was approved by the Research Ethics Board at 
Western University Canada, and all volunteers provided written informed consent prior to 
imaging (Appendix A). Knees were deemed healthy if volunteers denied experiencing 
knee pain on most days of the weeks prior to this study and had not been diagnosed with 
any type of knee arthritis. Volunteers with prior knee injuries and/or surgeries that 
occurred before the year leading up to the study were not excluded from the cohort if they 
denied experiencing frequent knee symptoms including pain, aching, or stiffness on most 
days of the weeks prior to this study. 
2.2.1 Image acquisition 
MRI scans were acquired on a 3.0 Tesla MR system (General Electric Healthcare, 
Milwaukee, WI, USA) using a 3D Multiple Echo Recombined Gradient Echo (MERGE) 
sequence in accordance with the OARSI recommendations for KOA imaging clinical 
trials.22 The MERGE sequence is a T2*-weighted pulse sequence for musculoskeletal 
imaging that enables direct visualization of FAC. An HD T/R Knee Array Coil (8 
Channels) was used while volunteers were positioned supine with minimal knee flexion. 
Images were acquired in the sagittal plane with voxel sizes of 0.63 x 0.63 x 0.40 mm3, an 
average of 250 slices, a reconstructed matrix size of 256 by 256 voxels, and an FOV of 
16 cm. The excitation flip angle was 5° with a repetition time (TR) of 30 ms and an echo 
time (TE) of 11.71 ms. The MERGE sequence scan time for one knee was 4 minutes and 





3D US images were acquired using an Aplio i800 US machine (Canon Medical Systems 
Corporation, Ōtawara, Tochigi, Japan) equipped with a 14L5 linear transducer with a 58 
mm footprint length and an operating frequency of 10 MHz (3.8 MHz – 10.0 MHz). The 
2D US transducer was mounted to our 3D US scanner using a custom 3D-printed mould 
(Fig. 1). Our 3D US device consisted of a motorized drive mechanism that linearly 
translated the transducer over 4.0 cm along the patient’s skin. 2D US images were 
continually acquired at regular spatial intervals which were reconstructed into a 3D image 
immediately after scanning via computer software.18 Our 3D US scanner has previously 
been validated on tungsten filament phantoms and volumetric agar phantoms, 
demonstrating the ability to acquire Euclidean distance and volumetric measurements 
with errors < 2%.23 For 3D US acquisition, volunteers were positioned supine and 
instructed to flex their knee to the maximum range of motion without eliciting pain. 3D 
US images of the tFAC were acquired at the distal end of the femur, proximal to the 
patella during maximum knee flexion (Fig. 2). 120 2D US images were acquired in the 
transverse plane with transducer translation along the perpendicular axis. Reconstructed 
3D US image voxel sizes were 0.058 x 0.058 x 0.33 mm3 with 2D US in-plane image 
dimensions of 968 x 694 voxels. 3D US acquisition time was 15 seconds for one knee. 
The time period between MRI and 3D US imaging sessions was as short as possible 












Figure 2.1 (A) Schematic diagram of our handheld mechanical 3D US acquisition 
device. The conventional US transducer (gray) is mounted to a motorized drive 
mechanism (green) via a custom 3D-printed transducer mould (purple). Pressing the 
button located on the top of the device initiates a 3D US acquisition. (B) Image of the 3D 














2.2.2 Manual segmentation 
MRI voxel resampling was performed to ensure that the segmentation pixel spacings 
were substantially smaller than the smallest FAC image feature. Voxel resampling was 
conducted in MATLAB R2019b (MathWorks, Natick, Massachusetts, USA) using the 
interp2 function with the spline interpolation method. The resampled voxel size was 0.15 
x 0.15 x 0.40 mm3 to provide a balance between segmentation sensitivity and 
computation time. 
Manual tFAC segmentations were completed by two raters (SP, RD) on MRI and 3D US 
after receiving training during three formal calibration sessions with a rheumatologist 
possessing advanced diagnostic and interventional musculoskeletal ultrasonography 
training (CTA). One rater had no prior experience with medical image segmentation but 
possesses a medical physics academic background with courses in medical imaging 
modalities including US and MRI. The other rater is a registered diagnostic medical 
sonographer with formal training and clinical experience in medical imaging. 
Segmentations were performed in the open-source software 3D Slicer (3D Slicer 4.11.0 
Preview Release) using the segment editor module and were conducted in the sagittal 
MRI and transverse 3D US planes.24 Segmentations of both MRI and 3D US were 
completed using every second 2D image to decrease segmentation time for both 
modalities without a reduction in sensitivity to tFAC volume changes.25 Segmented 2D 
images were interpolated using a morphological contour interpolation algorithm in 3D 
Slicer, resulting in an average of 146 and 92 segmented 2D images per MRI and 3D US 
image, respectively.26 Both raters were blinded to the other imaging modality during 
segmentations such that MRI segmentations were completed without the help of 3D US 
image and vice versa. Each rater completed segmentations in a random order on each 
modality. 
During MRI segmentations, the posterior condylar cartilage was excluded by defining the 
anterior border of the posterior aspect of the lateral and medial menisci as a segmentation 
border to further reduce segmentation times (Fig. 3a, b). The hyperintense synovial 
membrane lining Hoffa’s fat pad was excluded from MRI segmentations. For 3D US 





cortex were defined as boundaries for the anechoic cartilage (Fig. 3c, d). With these 
boundaries and definitions, total segmentation times were approximately 45 to 60 
minutes per knee for MRI and 20 to 30 minutes per knee for 3D US. Five knees from 
separate volunteers were randomly selected by each rater and re-segmented on MRI and 
3D US. Repeated segmentations were conducted during sessions separated by a two-
week “washout” period to reduce the probability of each rater relying on memory when 
conducting a repeated segmentation. 
Figure 2.3 MERGE MRI (A) and 3D US (C) images of the trochlear articular knee 
cartilage outlined by the white arrows in the sagittal MRI and transverse US planes of a 
healthy volunteer, accompanied by the same images with an overlaid MRI (B) and 3D 





2.2.3 Reliability and validation analysis 
MRI and 3D US segmentations were registered via manual initialization followed by 
automated surface-based registration in 3D Slicer (Fig. 4). Initialization involved 
manipulating 3D US tFAC models using linear transformations and rotations along the 
three Cartesian axes to align the segmentations with MRI using the intercondylar notch as 
an anatomical landmark. An automatic surface-based registration method (Jean-Baptiste 
& Vinicius Boen, University of Michigan) was applied to the segmentations to complete 
the registration. Intra- and inter-rater reliabilities were assessed using the same 
registration procedures. Reliability analysis was conducted using the entire segmented 
area of MRI and 3D US tFAC models, while validation between modalities involved 
additional trimming of MRI segmentations. MR images captured a larger FAC FOV than 
3D US, resulting in segmentations that did not represent identical anatomical ROI when 
comparing modalities. Therefore, MRI segmentations were manually trimmed using the 
overlaid 3D US segmentations as guides, ensuring that tFAC models represented the 
same ROI on both modalities. Registration and trimming were repeated on five knees 
selected at random during sessions separated by a two-week “washout” period.  
Segmentation volumes were computed by 3D Slicer, and the percent differences between 
MRI and 3D US volumes were calculated. The mean surface distance (MSD), Hausdorff 
distance (HD), and Dice similarity coefficient (DSC) were computed as these metrics are 
widely used to compare and evaluate segmentations.27 MSD represents the mean distance 
from a point on one surface to the nearest corresponding point on the other surface, while 
HD is the largest distance from a point on one surface to the closest point on the other 
surface (Fig 4e). DSC provides a measure of similarity in terms of overlap between 
segmentations and ranges from 0% (no overlap) to 100% (identical objects). MSD and 
HD values were computed using the open-source software CloudCompare 
(CloudCompare v2.11 beta), and DSC values were computed using the segment 






Figure 2.4 Manual segmentations of the FAC from MRI (A) and 3D US (B) images. 3D 
US segmentations were registered to MRI using a semi-automated surface-based 
registration algorithm (C). MRI segmentations were then trimmed (D) to ensure both 
MRI and 3D US segmentations covered the same cartilage region for comparison 
purposes. (E) Colour map representing the absolute distance (mm) between a given MRI 
and 3D US segmentation pair from the same knee of a volunteer. The distance map has 
been overlaid on the 3D US segmentation and represents the distance from each point to 





2.2.4 Statistical analysis 
Statistical analyses were performed using SPSS (SPSS Statistics v26; IBM, Armonk, NJ). 
All data were initially tested for normality using the Shapiro-Wilk test. Intra- and inter-
rater segmentation reliabilities from MRI and 3D US for both raters were assessed using 
intraclass correlation coefficients (ICCs). Intra-rater ICCs were based on a single-rating, 
absolute-agreement, 2-way mixed-effects model, while inter-rater ICCs were based on a 
single-rating, absolute-agreement, 2-way random-effects model. ICCs were interpreted as 
less than 0.50 indicating poor reliability, between 0.50 and 0.75 indicating moderate 
reliability, between 0.75 and 0.90 indicating good reliability, and greater than 0.90 
indicating excellent reliability.28 Bland-Altman plots were used to assess differences 
between intra- and inter-rater tFAC volumes along with differences between MRI and 3D 
US segmentations. A cumulative percentile plot was used to observe the relationship of 
the differences between MRI and 3D US tFAC volumes. Correlations between tFAC 
volumes calculated as the mean of the two raters from MRI and 3D US segmentations 
were determined using Spearman Rank-Order Correlation due to the non-normal 
distribution of data. Linear regression analysis was conducted using MRI segmentation 
volumes as predictors for 3D US tFAC volumes and the enter method for equation 
construction. 
2.3 Results 
The demographic data of the volunteers are shown in Table 1 and was available from 24 
of the 25 participants. 
Table 2.1 Demographic data of twenty-four out of the twenty-five volunteers. 
 Volunteers with healthy knees 
% Women 58.3 
Age [year] (mean ± SD) 29.9 ± 14.5 
Height [m] (mean ± SD) 1.68 ± 0.11 
Weight [kg] (mean ± SD) 67.0 ± 14.8 






Similar mean segmentation volumes and mean absolute volume differences between 
intra- and inter-rater comparisons were observed using the same modality for each rater 
(Table 2, Fig. 5). The smallest ICC was 0.83 (0.48, 0.94) and was observed for the inter-
rater comparison of MRI, while the largest ICC was 1.00 (0.98, 1.00) and was observed 
for the intra-rater 3D US comparison for rater 1 (Table 3). Global mean MSD and HD 
were smaller for 3D US than MRI for intra- and inter-rater comparisons, while DSC was 
larger for 3D US than MRI during all comparisons (Table 3). 
Table 2.2 Mean volumes ± standard deviations (SDs) for all intra-rater and inter-rater 
comparisons, along with the absolute volume difference ± SD between MRI and 3D US. 
The mean volumes and absolute differences for repeated registrations and trimmings of 








Intra-rater (n = 5)    
MRI (rater 1) 4.71 ± 1.18 4.76 ± 1.20 0.232 ± 0.152 
MRI (rater 2) 4.56 ± 1.10 4.20 ± 1.04 0.366 ± 0.351 
3D US (rater 1) 2.52 ± 1.01 2.53 ± 0.96 0.0516 ± 0.0531 
3D US (rater 2) 2.15 ± 0.92 2.17 ± 1.08 0.167 ± 0.111 
    
Inter-rater (n = 25)    
MRI 4.79 ± 1.23 4.38 ± 1.03 0.494 ± 0.465 
3D US 2.29 ± 0.72 2.30 ± 0.64 0.155 ± 0.134 
    
Registration & trimming (n = 5)   









Figure 2.5 Bland-Altman plots assessing intra-rater test/re-test reliability of rater 1 with 
MRI (A) and 3D US (B), and rater 2 with MRI (C) and 3D US (D). Bland-Altman plots 
assessing inter-rater reliability between the two raters using MRI (E) and 3D US (F) to 
complete segmentations. Mean differences in segmentation volumes are indicated by a 





Table 2.3 Intra- and inter-rater reliability ICCs with 95% confidence intervals (CIs) for 
manual MRI and 3D US segmentations, along with repeated MRI and 3D US 
registrations and trimmings. The MSD, HD, and DSC values ± SD for all comparisons 
are also presented. 
 
ICC (95% CI) P value MSD [mm] HD [mm] DSC [%] 
Intra-rater (n = 5)    








87.3 ± 2.8 








83.5 ± 4.6 








92.9 ± 0.2 








88.1 ± 2.6 
      


















86.4 ± 3.1 
      









94.3 ± 4.4 
2.3.2 3D US to MRI registration and trimming 
The mean percent difference between MRI and 3D US volumes averaged across all 
comparisons including both raters individually, following registration and trimming, was 
16.7 ± 12.9 % (n = 50). 3D US tFAC volume measurements were larger than MRI 
volume measurements in 88% of the comparisons between the two modalities (Fig. 6a, 
b). Spearman Rank-Order Correlation revealed a strong correlation between MRI and 3D 
US volumes (ρ = 0.884 (0.746, 0.949), p < 0.0001), and linear regression resulted in R2 = 
0.848 (0.750, 0.950), p < 0.0001, and Y = 1.29 * X – 230 (Fig. 6c). Global mean MSD, 
HD, and DSC between registered segmentations averaged between both raters were 0.375 






Figure 2.6 (A) Bland-Altman plot assessing the relationship between MRI and 3D US 
segmentation volumes as the mean for both raters. Mean differences in segmentation 
volumes are indicated by a solid line and the mean ±1.96 SD are indicated by dashed 
lines. (B) Cumulative percentile plot depicting the volume difference between MRI and 
3D US segmentations averaged between both raters. (C) Linear regression plot of MRI 
segmentation volumes used as a predictor for 3D US. A line of equality is represented by 
the dashed line. 
2.4 Discussion 
This is the first study investigating the reliability and validation of FAC volume 





tFAC volumes, which is important when studying the status and progression of KOA 
affecting patellofemoral (PF) articulation. Since KOA affects the entire joint, these 
results are pertinent to the study of nearly all KOA phenotypes. Healthy FAC possesses a 
relatively smooth and continuous surface without distinct anatomical landmarks that can 
be used for registering segmentations, besides the intercondylar notch. Therefore, tFAC 
images that included the intercondylar notch enabled registration of MRI and 3D US 
segmentations. Additionally, the intercondylar notch can be used as an anatomical 
landmark during longitudinal studies to ensure repeated measures are taken from the 
same ROI. 
3D US imaging is possible in any application involving 2D US since the only 
modification required is mounting the 2D US transducer to a 3D US scanning device. 
Several studies have previously investigated the application of 2D US for evaluating 
femoral condylar cartilage for KOA assessments29,30,31,32. However, quantitative image 
analysis of non-invasive knee US has only been reported for cartilage thickness 
measurements but not entire cartilage volumes33,34,35. Quantitative image analysis may 
provide more sensitive information regarding early KOA than semi-quantitative grading 
scales, which are subjective and potentially susceptible to US operator/rater differences. 
However, semi-quantitative grading scales are potentially faster than manual quantitative 
image analysis. Therefore, this study builds on previous work and is easily implemented 
in similar clinical settings. 
Many studies have investigated cartilage thickness measurements for assessing KOA 
severity36,37. However, thickness measurements are highly variable and dependent on the 
FAC ROI being measured, which can vary within subjects due to US transducer 
placement and angulation at different time points38,39,40. Detecting changes in cartilage 
loss using thickness measurements requires the ability to sample the same ROI with good 
test-retest reliability. Volume measurements may overcome these limitations by enabling 
quantification of cartilage loss in all dimensions and provide a similar metric to average 
cartilage thickness. Furthermore, 3D US may provide meaningful advantages over MRI 
for quantifying FAC volume. Our 3D US device is compatible with any commercially 





Additionally, the portability of our 3D US device enables FAC volume measurements to 
be acquired at the patient’s bedside. 
2.4.1 Reliability 
Intra-rater ICCs for MRI and 3D US demonstrated excellent reliabilities (> 0.90). Inter-
rater ICC for MRI demonstrated good reliability (0.75 – 0.90) while 3D US ICC 
demonstrated excellent reliability (> 0.90). Intra- and inter-rater Bland-Altman plots 
displayed smaller volume difference variations for 3D US compared to MRI in all 
comparisons (Fig. 5). Additionally, global mean MSD and HD were smaller for 3D US 
than MRI, and mean DSC for 3D US was higher than MRI for intra- and inter-rater 
comparisons (Table 3). Collectively, these results suggest that our 3D US system can 
quantify tFAC volume with similar or perhaps superior reliability and precision than 
MRI. 
The higher spatial resolution of 3D US images acquired with the Canon 14L5 linear 
transducer compared to 3.0 Tesla MRI may partially account for reliability and precision 
differences. Resolution differences between modalities were most apparent during MRI 
segmentations when raters attempted to define the interface between tFAC and the 
synovial lining of Hoffa’s fat pad. Differentiating tFAC from slightly hyperintense 
synovial lining proved extremely difficult or impossible during MRI segmentations 
despite manipulating image contrast. Additionally, the TF cartilage interface was difficult 
to identify on MRI as both cartilage structures were equally hyperintense. The synovial 
lining of Hoffa’s fat pad along with the TF contact point were not within the ROI of 3D 
US acquisitions since images were acquired during maximum knee flexion. Healthy FAC 
produced ideal US images with excellent differentiation from surrounding tissues. The 
difficulties in identifying borders on MRI likely also contributed to higher segmentation 
times compared to 3D US. The MRI and 3D US resolutions were chosen to match what is 
routinely used in both patient care and clinical trials for OA to enable comparisons in a 






3D US tFAC segmentations possessed larger volumes than MRI segmentations. 
Considering the higher spatial resolution of US compared to MRI, it is possible that MRI 
segmentations were not able to capture the true cartilage volume as effectively as 3D US. 
Medial and lateral portions of the tFAC and condylar cartilage become thin and difficult 
to delineate from thin adipose tissue and may often not be visible in MRI. Due to the high 
spatial resolution of 3D US, the thin medial and lateral portions of tFAC were easily 
identified and therefore included in segmentations. This will be of great importance in 
clinical studies of joint disease since thinner areas of cartilage are particularly susceptible 
to damage and loss in KOA. Our 3D US device was able to visualize tFAC and condylar 
cartilage regions that were difficult or impossible to visualize using MRI, providing a 
more comprehensive model of the cartilage and improved volume quantifications. 
Notwithstanding these differences in absolute cartilage volumes, Spearman Rank-Order 
Correlation and linear regression analyses revealed a strong correlation between MRI and 
3D US tFAC measurements and that MRI tFAC volumes can predict 3D US volumes. 
2.4.3 Limitations and impact 
This study was conducted on volunteers with healthy knees rather than KOA patients. 
Validating our 3D US system on healthy knees prior to testing with KOA patients was a 
necessary first step for developing image acquisition, segmentation, and analysis 
protocols. In KOA patients, FAC characteristically develops fissures, abrasions, and other 
surface irregularities, whereas healthy cartilage is smooth and continuous. Therefore, 
before implementing our 3D US device clinically, the measurement properties of this 
system should also be evaluated in KOA patients. Results from a KOA patient study will 
enable us to determine if KOA cartilage pathology impacts measurement properties of 
our system relative to healthy cartilage. However, given the high resolution and excellent 
soft-tissue contrast of clinical US systems, we anticipate our 3D US system will perform 
similarly in KOA patients. 
Only a portion of FAC was captured in a single pass 3D US acquisition as the FAC 





scanned in maximum flexion proximal to the patella to capture the greatest portion of 
FAC possible. However, during maximum knee flexion, the posterior medial and lateral 
condylar cartilage are in contact with the tibial cartilage and are not visible with 3D US. 
This limitation can be overcome if the tFAC is used as a non-invasive imaging “biopsy” 
of knee cartilage, providing clinicians with an indication of FAC status representative of 
overall joint health. Additionally, manual trimming of MRI segmentations to match the 
3D US ROI was only necessary for validating our system against MRI and would not be 
required when using 3D US independently in future studies. While this procedure may 
have introduced variability or bias, repeated registrations, along with repeated trimming, 
revealed nearly perfect reproducibility (Table 3), indicating that our protocol results in 
very little variability or bias. 
The weight-bearing condylar cartilage was able to be visualized using our 3D US device. 
However, this required additional acquisitions on the medial and lateral sides of the 
patella during maximum knee flexion. Since MR images of FAC were acquired during 
minimal knee flexion, variations in patella positioning relative to the FAC surface in MRI 
compared to 3D US resulted in difficulties registering 3D US condylar cartilage 
segmentations to MRI. Therefore, this study focused on the tFAC region for validation 
with MRI, but 3D US could be used for monitoring condylar cartilage volume changes 
over time without requiring MRI comparisons. Finally, a small subset of patients with 
severe KOA may experience limited range of motion, which might interfere with 
visualization of the most inferior aspects of the tFAC. 
The greatest advantage of our 3D US system is the ability to acquire images quickly, 
easily, and comfortably at the patient’s bedside, providing cost-effective and non-
invasive assessments of FAC status for reliable longitudinal monitoring. Our 3D US 
device could alter the workflow of orthopedic, sports medicine, primary care, and 
arthritis clinics by enabling clinicians and researchers to obtain more information without 
added complexity or additional stress and discomfort to patients. This technology may be 
well-suited to longitudinal and interventional clinical studies where detecting changes in 
cartilage volume is required. In the future, this system will also be useful in a routine 





insensitive to change and relies on indirect features of FAC thinning. MRI-based 
measures of cartilage volume are superior to radiographic measures but are limited by 
cost, time, accessibility, and patient-related factors, preventing generalized use of 
quantitative MRI for KOA. Our study demonstrates that cartilage volume measurements 
acquired using 3D US represent a more feasible method to quantitatively assess tFAC 
volume with very high reliability and accuracy. 
In conclusion, we have demonstrated the reliability and validity of a handheld mechanical 
3D US device we developed to quantify tFAC volumes in healthy volunteers. We 
demonstrated that 3D US segmentations are associated with excellent intra- and inter-
rater reliabilities and possess strong agreement with MRI tFAC volume measurements. 
The tFAC is a vital region of the knee joint for investigating the progression of PF OA 
and could also be used as a non-invasive imaging “biopsy” of the FAC to monitor KOA 
progression and response to treatment. Future work will assess the reliability of our 3D 
US device in KOA patients and the ability to monitor FAC volume changes over time. 
Further assessment of measurement properties, including sensitivity to change, is 
necessary before its use can be recommended in clinical trials. Future work will also 
assess the test-retest reliability of 3D US during image acquisitions separated by time. In 
addition to longitudinal construct validity, future work will also assess the intra- and 
inter-rater reliability of 3D US cartilage measurements in a longitudinal study to monitor 
the progression of tFAC change and degradation for early detection of KOA. 3D US is a 
promising, inexpensive, and widely accessible imaging modality for POC assessments of 
KOA and will enable clinicians and researchers to obtain additional information without 
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Chapter 3  
3 Conclusion and future directions 
This chapter revisits the overarching aims of this thesis and summarizes the findings from 
Chapter 2. This chapter also explores the limitations of this work with potential solutions 
and discusses directions for future work. 
3.1 Overview and research objectives 
KOA is one of Canada’s most common chronic health conditions and causes patients to 
suffer from debilitating pain, disability, and a decreased quality of life.1,2 X-ray 
radiography and MRI are the current clinical standards for diagnosing and monitoring the 
progression of KOA and its response to treatment. However, radiographic grading has 
poor sensitivity for detecting FAC changes in early KOA and has poor soft-tissue 
contrast for visualizing FAC.3 MRI is not feasible for POC KOA assessments due to its 
high manufacturing and operating costs, long acquisition times, and inaccessibility to all 
patients at all times.4 Conventional 2D US is an alternative, widely accessible, and more 
cost-effective imaging modality for monitoring KOA at the patient’s bedside. However, 
there are several critical limitations associated with 2D US. Operators must cognitively 
reconstruct the necessary 3D anatomy through several 2D images, leading to variability. 
Additionally, tissue volume measurements using 2D US are associated with low 
accuracy, high variability, and large operator dependency.5 Alternatively, 3D US imaging 
techniques involve translating a 2D US transducer while continually acquiring 
consecutive images that are reconstructed into a 3D image following an acquisition. 3D 
US imaging has the potential to overcome the limitations associated with 2D US and may 
fill the clinical need for a POC imaging tool to monitor KOA progression and response to 
treatment. 
The purpose of this work was to investigate the application of 3D US imaging for 
measuring FAC volume without the limitations associated with x-ray radiography and 
MRI. The central hypothesis of this thesis was that 3D US imaging could be used to 





standard of MRI. This thesis sought to test this hypothesis through the following 
objectives: 
1. Assess the intra- and inter-rater reliabilities of manual FAC segmentations of 
healthy knees from MRI and 3D US. 
2. Assess the validity of segmentation-based FAC volume measurements using 3D 
US compared to the current clinical standard of MRI in healthy knees. 
3.2 Summary 
In Chapter 2, the reliability and validity of our handheld mechanical 3D US imaging 
device were tested by comparing manual FAC volume quantifications against MRI. 
Bilateral knee images of 25 healthy volunteers were acquired with MRI and our 3D US 
scanner. MRI scans were acquired using a 3.0 Tesla General Electric Healthcare system 
with a 3D MERGE acquisition sequence. 3D US scans were acquired using a Canon 
Medical Systems Aplio i800 US machine equipped with a 14L5 linear transducer. Two 
raters manually segmented the tFAC from both MRI and 3D US after receiving training 
from a rheumatologist with advanced diagnostic and interventional musculoskeletal 
ultrasonography experience. Each rater repeated segmentations on five cases during 
separate sessions to assess intra-rater reliability. 3D US and MRI segmentations were 
registered using a semi-automated surface-based registration algorithm. The MRI 
segmentations were trimmed to match the same FAC ROI from 3D US to enable direct 
volume comparisons. Intra- and inter-rater reliabilities were assessed using ICCs 
calculated from the segmentation volumes. Spearman correlation and linear regression 
were used to evaluate the relationships between MRI and 3D US tFAC volumes. 
MRI intra-rater ICCs were 0.97 (0.79, 1.00) and 0.90 (0.25, 0.99) for each rater, with an 
inter-rater ICC of 0.83 (0.48, 0.94). 3D US intra-rater ICCs were 1.00 (0.98, 1.00) and 
0.98 (0.84, 1.00) for each rater, with an inter-rater ICC of 0.96 (0.90, 0.98). Spearman 
correlation and linear regression revealed a strong correlation ρ = 0.88 (0.75, 0.95) and 
regression R2 = 0.85 (0.75, 0.95). These results indicate that 3D US is associated with 





quantifying healthy tFAC volume with manual segmentations. 3D US imaging has the 
potential to greatly improve feasibility for quantifying knee cartilage volume during 
KOA clinical trials and patient care. 
3.3 Limitations 
This study was conducted on volunteers with healthy knees and not patients diagnosed 
with KOA. In diseased patients, the FAC develops surface abnormalities such as fissures, 
abrasions, divots, and other irregularities. Therefore, the measurement properties of our 
3D US device need to be evaluated in KOA patients before clinical implementation. 
Additionally, 3D US imaging possesses a smaller FOV than MRI, making it difficult to 
visualize the entire FAC in a single 3D US image. It is possible to visualize the weight-
bearing femoral condylar cartilage using 3D US with additional acquisitions. However, 
variations in the patella position relative to the cartilage surface in MRI compared to 3D 
US resulted in difficulties registering condylar cartilage segmentations between 
modalities. 
Due to the large acoustic impedance mismatch between soft tissue and bone, US imaging 
cannot visualize the FAC through the patella and tibia. Therefore, knees were imaged 
during maximum flexion with 3D US to reveal the largest possible region of FAC 
without obstruction by the tibia. The bore size of MRI scanners cannot accommodate legs 
under full knee flexion, making it impossible to acquire MR images of the knee in the 
same orientation as 3D US images. The differences in the degree of knee flexion between 
MRI and 3D US acquisitions result in variations in the patella position along the trochlear 
groove. These variations introduced complications when identifying the intercondylar 
notch for registering MRI and 3D US segmentations. However, registering FAC 
segmentations between MRI and 3D US is only necessary for validating our 3D US 
device against MRI. When using 3D US independently in the clinic and future studies, 





3.4 Future directions 
The results of this work highlight the potential of 3D US for use as an objective, imaging-
based POC tool to assess KOA status, progression, and response to treatment. In Chapter 
2, FAC volume measurements were acquired using our handheld mechanical 3D US 
device and validated against MRI in healthy volunteers. A study investigating the 
reliability and validity of our 3D US device for quantifying FAC volume in patients 
diagnosed with KOA will be conducted to expand beyond healthy volunteers and provide 
further evidence for clinical feasibility. Longitudinal studies using 3D US to monitor 
FAC volume changes in healthy volunteers and KOA patients should also be conducted 
to evaluate 3D US’s sensitivity to cartilage volume changes. 
Future studies will also investigate the application of our 3D US device for monitoring 
knee synovitis. Synovitis and the resultant pro-inflammatory mediators are essential 
components in the pathogenesis of KOA.6,7 Synovitis may also be linked to heightened 
pain sensitivity through sensitization and activation of sensory neurons.8,9 Monitoring 
changes in synovial volume with 3D US may provide insight into the complex 
relationship between synovitis, pain, and KOA. However, synovitis can cause the 
synovium to expand to several times the size of its healthy state, making it difficult to 
visualize the entire synovium in a single 3D US image. Furthermore, there is an absence 
of rigid anatomical landmarks in the suprapatellar synovium region, making it 
challenging to register several images. To address these challenges, we have developed a 
counterbalanced POC system that can track the position of 3D US acquisitions in 3D 
space. The tracking information enables merging multiple 3D US acquisitions to 
visualize the entire suprapatellar synovium in a single image. The POC system features a 
multi-jointed arm linkage with electromagnetic encoders at each joint to compute the 
position and orientation of our 3D US device using forward kinematics. The tracking 
accuracy of the POC system was validated using an external optical tracking system, 
demonstrating an overall mean absolute tracking error of 3.08 ± 2.01 mm with no 
difference between the two tracking systems (p = 0.965).10 Future work will decrease the 
POC system’s tracking error and test the image registration capabilities using volumetric 





Another direction for future work is to develop automatic cartilage segmentation 
algorithms with deep learning. Several studies have investigated the application of deep 
learning for automatic knee cartilage segmentations.11,12,13 Manual 3D US cartilage 
segmentations are time-consuming and subject to operator dependencies. Automatic 
segmentation will enable clinicians to measure FAC volume directly at the patient’s 
bedside using 3D US. Future studies will also investigate monitoring synovitis using 3D 
US and deep learning. 
3.5 Conclusion 
In conclusion, this thesis investigates applying a handheld mechanical 3D US device for 
monitoring KOA progression and response to treatment at the patient’s bedside. The 
study described in this thesis demonstrates that 3D US FAC volume measurements are 
associated with excellent reliability and strong concurrent validity with the current 
clinical standard of MRI. 3D US imaging is a promising, widely accessible imaging 
modality for POC assessments of KOA and will enable clinicians and researchers to 
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